Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Light-controllable charge-reversal nanoparticles with polyinosinic-polycytidylic acid for enhancing immunotherapy of triple negative breast cancer
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-06-16
DOI
10.1016/j.apsb.2021.06.006
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer
- (2021) Chuan Hu et al. ADVANCED FUNCTIONAL MATERIALS
- Shape Transformable Strategies for Drug Delivery
- (2021) Wenfeng Jia et al. ADVANCED FUNCTIONAL MATERIALS
- Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer
- (2020) Romualdo Barroso-Sousa et al. CLINICAL CANCER RESEARCH
- Pembrolizumab for triple-negative breast cancer
- (2020) Robert Stirrups LANCET ONCOLOGY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Nanoparticle Electrostatics and Protein–Protein Interactions on Corona Formation: Conformation and Hydrodynamics
- (2020) Hwankyu Lee Small
- Delivery strategies for macromolecular drugs in cancer therapy
- (2020) Qin Guo et al. Acta Pharmaceutica Sinica B
- Expanding the Role for Immunotherapy in Triple-Negative Breast Cancer
- (2020) Peter Savas et al. CANCER CELL
- Nanoparticle depots for controlled and sustained gene delivery
- (2020) Zhongyu Li et al. JOURNAL OF CONTROLLED RELEASE
- Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed
- (2020) Lei Fang et al. Science Advances
- The progress and perspective of nanoparticle-enabled tumor metastasis treatment
- (2020) Wei Zhang et al. Acta Pharmaceutica Sinica B
- The nanomaterial-induced bystander effects reprogrammed macrophage immune function and metabolic profile
- (2020) Peng Yuan et al. Nanotoxicology
- Small interfering RNA for cancer treatment: overcoming hurdles in delivery
- (2020) Nitin Bharat Charbe et al. Acta Pharmaceutica Sinica B
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
- (2019) D. Merino et al. Nature Communications
- Facile Hydrophobization of siRNA with Anticancer Drug for Non-Cationic Nanocarrier-Mediated Systemic Delivery
- (2019) Congfei Xu et al. NANO LETTERS
- Nonviral Gene Delivery with Cationic Glycopolymers
- (2019) Craig Van Bruggen et al. ACCOUNTS OF CHEMICAL RESEARCH
- Light‐Triggered In Situ Gelation to Enable Robust Photodynamic‐Immunotherapy by Repeated Stimulations
- (2019) Zhouqi Meng et al. ADVANCED MATERIALS
- Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
- (2019) Nina D’Abreo et al. Nature Reviews Clinical Oncology
- Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy
- (2019) Quan Zhou et al. Nature Nanotechnology
- Targeting peptide-decorated biomimetic lipoproteins improve deep penetration and cancer cells accessibility in solid tumor
- (2019) Tao Tan et al. Acta Pharmaceutica Sinica B
- Cdk5 knocking out mediated by CRISPR-Cas9 genome editing for PD-L1 attenuation and enhanced antitumor immunity
- (2019) Huan Deng et al. Acta Pharmaceutica Sinica B
- Engineering nanoparticles to locally activate T cells in the tumor microenvironment
- (2019) Dangge Wang et al. Science Immunology
- Self‐Amplified Drug Delivery with Light‐Inducible Nanocargoes to Enhance Cancer Immunotherapy
- (2019) Bing Feng et al. ADVANCED MATERIALS
- Nanomedicine‐Based Immunotherapy for the Treatment of Cancer Metastasis
- (2019) Pengcheng Zhang et al. ADVANCED MATERIALS
- Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
- (2019) Lei Miao et al. NATURE BIOTECHNOLOGY
- The Chemistry of Boronic Acids in Nanomaterials for Drug Delivery
- (2019) Alexandra Stubelius et al. ACCOUNTS OF CHEMICAL RESEARCH
- Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy
- (2019) Weijing Yang et al. ACS Nano
- Implantable Synthetic Immune Niche for Spatiotemporal Modulation of Tumor-Derived Immunosuppression and Systemic Antitumor Immunity: Postoperative Immunotherapy
- (2018) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Responsive Assembly of Upconversion Nanoparticles for pH-Activated and Near-Infrared-Triggered Photodynamic Therapy of Deep Tumors
- (2018) Fangyuan Li et al. ADVANCED MATERIALS
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
- (2018) Tingting Wang et al. Nature Communications
- Ultrafast charge-conversional nanocarrier for tumor-acidity-activated targeted drug elivery
- (2018) Jing Liu et al. Biomaterials Science
- Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84): A randomised phase III trial
- (2018) Andreas Schneeweiss et al. EUROPEAN JOURNAL OF CANCER
- A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy
- (2018) Liangliang Dai et al. Advanced Science
- Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody
- (2016) Chao Wang et al. ADVANCED MATERIALS
- Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
- (2016) Dangge Wang et al. NANO LETTERS
- Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines
- (2016) Hong-Xia Wang et al. Nano Today
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial
- (2015) Hideo Shigematsu et al. Clinical Breast Cancer
- Combinatorial Immunotherapy of Polyinosinic–Polycytidylic Acid and Blockade of Programmed Death-Ligand 1 Induce Effective CD8 T-cell Responses against Established Tumors
- (2014) Toshihiro Nagato et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started